Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey
Micafungin was reported to be non-inferior to liposomal amphotericin B (LAmB) in treating patients with candidaemia and invasive candidiasis (IC). The current study aimed to evaluate the economic impact of using micafungin versus LAmB for treatment of candidaemia and IC in Turkey. A decision analyti...
Published in: | European Journal of Clinical Microbiology and Infectious Diseases |
---|---|
Main Author: | Neoh C.F.; Senol E.; Kara A.; Dinleyici E.C.; Turner S.J.; Kong D.C.M. |
Format: | Article |
Language: | English |
Published: |
Springer Verlag
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049144871&doi=10.1007%2fs10096-018-3312-9&partnerID=40&md5=81f64e080624db11c3deb824749b6315 |
Similar Items
-
Pharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey
by: Neoh C.F.; Senol E.; Kara A.; Dinleyici E.C.; Turner S.J.; Kong D.C.M.
Published: (2018) -
Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey
by: Neoh C.F.; Senol E.; Kara A.; Dinleyici E.C.; Turner S.J.; Kong D.C.M.
Published: (2017) -
The application of VR panoramic technology in B&B design strategies-taking the B&B in southern anhui as an example
by: Junhua X.; Abidin S.Z.; Vermol V.V.
Published: (2024) -
Digital Touchpoints and their Influence on Customer Preference for the B2B Mark
by: Haron, et al.
Published: (2023) -
Exploring Managers’ Perceptions on Sponsorship Relations and Decision Making in the Malaysian B2B Context
by: Sharipudin M.-N.S.; Hassim N.; Ayub S.H.; Fam K.-S.; Meekaewkunchorn N.
Published: (2023)